Regeneron Pharmaceuticals
The Director, Data Management Process, Quality, and Inspection Readiness provides strategic leadership for data management quality, inspection readiness, and process excellence within a global clinical development environment. This role establishes standardized approaches to governance and compliance, ensures adherence to GCP and regulatory requirements, and leads teams through health authority inspections. The position also drives continuous improvement of data management processes, training frameworks, and operational execution across the organization.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
17% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Manager, Clinical Compliance & Inspection Readiness
Olema Oncology
Senior Manager, Clinical Compliance & Inspection Readiness
Olema Oncology
Inspection Readiness Manager
Amgen
Inspection Readiness Manager
Amgen
Director, GCP Inspection Readiness and Audits Strategy
Kardigan
Regional Clinical Compliance Inspection Lead
BeOne Medicines